Elisa Gobbini (E Gobbini)

Publication Activity (10 Years)

Years Active: 2019-2022
Publications (10 Years): 3

Top Topics

Systematic Review

Advanced Non Small Cell Lung Cancer

Brain Metastases

Top Venues

Current oncology reports

Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico

Science immunology

This page only lists publications with an associated author ORCID identifier.

Publications

Caroline Plazy, Dalil Hannani, Elisa Gobbini
Immune Checkpoint Inhibitor Rechallenge and Resumption: a Systematic Review. Current oncology reports 24 (9) (2022)
Margaux Hubert, Elisa Gobbini, Coline Agnes Couillault, Thien-Phong Vu Manh, Anne-Claire Doffin, Justine Berthet, Céline Rodriguez, Vincent Ollion, Janice Kielbassa, Christophe Sajous, Isabelle Treilleux, Olivier Trédan, Bertrand Dubois, Marc Dalod, Nathalie Bendriss-Vermare, Christophe Caux, Jenny Valladeau-Guilemond
IFN-III is selectively produced by cDC1 and predicts good clinical outcome in breast cancer. Science immunology 5 (46) (2020)
Elisa Gobbini, R Chiari, P Pizzutillo, P Bordi, L Ghilardi, S Pilotto, G Osman, F Cappuzzo, F Cecere, F Riccardi, V Scotti, O Martelli, G Borra, E Maiello, A Rossi, P Graziano, V Gregorc, C Casartelli, C Sergi, A Del Conte, A Delmonte, C Bareggi, D Cortinovis, P Rizzo, F Tabbò, G Rossi, E Bria, D Galetta, M Tiseo, M Di Maio, S Novello
Real-world outcomes according to treatment strategies in ALK-rearranged non-small-cell lung cancer (NSCLC) patients: an Italian retrospective study. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 22 (3) (2019)